Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday’s

Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.

The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period.

Anavex Life Sciences shares fell 10% to $6.35 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

RedHill Biopharma Ltd. (NASDAQ:RDHL) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years' market exclusivity for Talicia.
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.
Tharimmune, Inc. (NASDAQ:THAR) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis.
Asset Entities Inc. (NASDAQ:ASST) gained 34% to $0.4703 after the company announced a stock repurchase program.
Captivision Inc. (NASDAQ:CAPT) rose 20.1% to $2.81 after surging 44% on Friday.
Perfect Corp. (NYSE:PERF) climbed 19.7% to $2.9944. The company on Monday announced the commencement of a tender offer to purchase shares above the current share price.
IO Biotech, Inc. (NASDAQ:IOBT) gained 19% to $1.3988. IO Biotech Chief Accounting Officer Brian Burkavage acquired a total of 10,000 shares at an average price of $1.01.
TC Biopharm (Holdings) Plc (NASDAQ:TCBP) gained 18.4% to $0.6680 after the company announced FDA clearance of the Phase 1B IND for TCB-008 in Acute Myeloid Leukemia.
Apollomics, Inc. (NASDAQ:APLM) shares rose 18.3% to $1.1750 after surging 14% on Friday. The company’s partner in China, Avistone Biotechnology Co. Ltd., recently received conditional approval from the National Medical Products Administration (NMPA) of China for the commercialization of vebreltinib to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC).
Safety Shot, Inc. (NASDAQ:SHOT) gained 17.8% to $4.2782.
ClearSign Technologies Corporation (NASDAQ:CLIR) gained 16% to $1.5665.
Affirm Holdings, Inc. (NASDAQ:AFRM) jumped 13.7% to $29.82 following reports of record 'buy now, pay later' predictions on Cyber Monday.
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) rose 13% to $3.72.
Oxbridge Re Holdings Limited (NASDAQ:OXBR) gained 12.5% to $1.2156.
IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) rose 12.4% to $9.13.
EHang Holdings Limited (NASDAQ:EH) gained 12.1% to $19.71.
Ituran Location and Control Ltd. (NASDAQ:ITRN) climbed 11.3% to $27.69 after the company reported third-quarter financial results.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) rose 10.2% to $31.93 after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.
Applied Optoelectronics, Inc. (NASDAQ:AAOI) gained 8.8% to $14.19.
Telecom Argentina S.A. (NYSE:TEO) rose 6.7% to $8.26.

Losers

10X Capital Venture Acquisition Corp. II (NASDAQ:VCXA) shares dipped 21.2% to $8.39.
BioNexus Gene Lab Corp. (NASDAQ:BGLC) fell 19.5% to $0.7246 after jumping 144% on Friday.
HCW Biologics Inc. (NASDAQ:HCWB) declined 14.5% to $1.00.
SharpLink Gaming Ltd. (NASDAQ:SBET) fell 14.4% to $1.49.
Innodata Inc. (NASDAQ:INOD) fell 14.2% to $5.80.
Reliance Global Group, Inc. (NASDAQ:RELI) declined 14% to $1.04.
SenesTech, Inc. (NASDAQ:SNES) fell 13.6% to $1.8738.
B. Riley Financial, Inc. (NASDAQ:RILY) dropped 11.2% to $18.61.
Puyi Inc. (NASDAQ:PUYI) declined 10.8% to $3.53.
TMC the metals company Inc. (NASDAQ:TMC) fell 10% to $1.2595.
HUYA Inc. (NYSE:HUYA) fell 7.4% to $3.5650.
Fisker Inc. (NYSE:FSR) declined 6.7% to $2.08.
Chewy, Inc. (NYSE:CHWY) fell 6.6% to $18.94.
Pagaya Technologies Ltd. (NASDAQ:PGY) fell 5.8% to $1.29 after the company said Michael Kurlander, Chief Financial Officer, has stepped down from his role to pursue an outside opportunity. The company named Deputy Chief Financial Officer Evangelos Perros as Interim Chief Financial Officer.
Polaris Inc. (NYSE:PII) fell 4% to $86.96.